IRIS
GALATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.153
NA - Nord America 1.259
EU - Europa 505
SA - Sud America 82
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 6
Totale 6.048
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.367
US - Stati Uniti d'America 1.211
CN - Cina 361
IT - Italia 246
HK - Hong Kong 149
BD - Bangladesh 142
GB - Regno Unito 68
FR - Francia 55
BR - Brasile 51
VN - Vietnam 38
DE - Germania 37
IN - India 25
CA - Canada 21
FI - Finlandia 19
NL - Olanda 17
MX - Messico 16
CZ - Repubblica Ceca 15
PL - Polonia 12
TR - Turchia 11
AR - Argentina 9
ZA - Sudafrica 8
ES - Italia 7
PE - Perù 7
SA - Arabia Saudita 7
CL - Cile 6
IQ - Iraq 6
MY - Malesia 6
UA - Ucraina 6
AU - Australia 5
PK - Pakistan 5
RU - Federazione Russa 5
SE - Svezia 5
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
JP - Giappone 3
PH - Filippine 3
TH - Thailandia 3
VE - Venezuela 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
GN - Guinea 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 6.031
Salva come PNG Salva come JPEG
Città #
San Jose 323
Singapore 257
Ashburn 210
Rome 152
Hong Kong 146
Beijing 119
Hefei 103
Dallas 75
Council Bluffs 70
Boardman 55
Columbus 52
London 50
Santa Clara 47
Lauterbourg 42
Shanghai 36
Munich 25
Los Angeles 24
New York 24
Seattle 17
Brno 15
Ho Chi Minh City 15
San Francisco 14
Mexico City 13
São Paulo 13
Buffalo 11
Turku 11
Amsterdam 10
Warsaw 10
West Jordan 10
Boston 9
Helsinki 8
Naples 8
Washington 8
Toronto 7
Orem 6
Pune 6
Guangzhou 5
Hanoi 5
Johannesburg 5
Las Vegas 5
Manchester 5
Montreal 5
Paris 5
Sona 5
Brooklyn 4
Chennai 4
Lima 4
Milan 4
Nairobi 4
Secaucus 4
Stockholm 4
Verona 4
Bologna 3
Chicago 3
Frankfurt am Main 3
Haiphong 3
Krasnodar 3
Kuala Lumpur 3
Lahore 3
Melbourne 3
New Orleans 3
Palermo 3
Philadelphia 3
Riyadh 3
Uberlândia 3
Augusta 2
Bangkok 2
Basra 2
Boydton 2
Cagliari 2
Cairo 2
Camden 2
Canberra 2
Caracas 2
Central 2
Charlotte 2
Cosenza 2
Dnipro 2
Florence 2
Genoa 2
Goiânia 2
Hangzhou 2
Hengshui 2
Jeddah 2
Kansas City 2
Kathmandu 2
Kirkuk 2
Manama 2
Manaus 2
Milwaukee 2
Modena 2
New Delhi 2
Phoenix 2
Poplar 2
Portsmouth 2
San Pedro Sula 2
Suffern 2
Taizhou 2
Tangshan 2
Tokyo 2
Totale 2.182
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 249
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 243
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 234
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 233
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 231
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 231
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 228
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 227
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 220
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 218
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 215
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 210
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 205
Assessment of liver function by the exhaled breath-print during chronic liver disease 205
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 175
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 172
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 138
Diabetes in chronic liver disease: from old concepts to new evidence 137
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 133
A challenging alfa-fetoprotein in a cirrhotic patient 133
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 122
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 118
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 111
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 110
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 107
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 92
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 75
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 71
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 71
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 70
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 69
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 66
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 60
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 59
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 56
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 56
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 55
Hepatic complications of bariatric surgery : the reverse side of the coin 54
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 53
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 51
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 51
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 50
Surgical complications after resection of adrenal carcinoma 48
GAS EXCHANGE AND PULMONARY MICROCIRCULATION ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC LIVER DISEASE PATIENTS FREE FROM HEPATOPULMONARY SYNDROME 48
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 44
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 43
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 41
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 41
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 41
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 40
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 38
Totale 6.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 4 0 0 2 0 0 5 0 0 72
2022/202333 6 0 1 1 0 2 9 4 0 1 9 0
2023/2024194 8 13 6 20 13 79 2 13 3 12 7 18
2024/20253.571 35 17 55 9 55 66 51 7 111 183 1.481 1.501
2025/20262.008 169 81 112 145 83 110 513 116 139 180 220 140
2026/2027159 43 116 0 0 0 0 0 0 0 0 0 0
Totale 6.048